Status:
COMPLETED
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
Lead Sponsor:
Pfizer
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.
Eligibility Criteria
Inclusion
- Symptoms of dry eye for at least 6 months.
- Signs of moderate to severe dry eye
Exclusion
- Women who are nursing or pregnant
- Participation in other studies within 30 days of screening visit
- Ocular disorders that may confound interpretation of study results
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
327 Patients enrolled
Trial Details
Trial ID
NCT00784719
Start Date
November 1 2008
End Date
October 1 2009
Last Update
April 9 2013
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chandler, Arizona, United States, 85286
2
Pfizer Investigational Site
Peoria, Arizona, United States, 85381
3
Pfizer Investigational Site
Phoenix, Arizona, United States, 85032
4
Pfizer Investigational Site
Artesia, California, United States, 90701